This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

20 - 22 October, 2025

Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Dr. Shuntaro Tsukamoto, PhD
Research Scientist, Tsukuba Research Laboratories at Eisai Co., Ltd.
Speaker

Profile

Shuntaro Tsukamoto (PhD)

2023- Research Scientist - Tsukuba Research Laboratories, Eisai
2022-2023 Postdoctoral Fellow - The Institute of Cancer Research, London
2013-2022 Research Scientist - Tsukuba Research Laboratories, Eisai
2008-2013 Graduate School of Agriculture, University of Kyushu, Ph.D.

Agenda Sessions

Delivery of a BET Protein Degrader via a CEACAM6-targeted Antibody-drug Conjugate Demonstrates Promising Anti-tumor Activity in Pancreatic Cancer Models
23 Oct, 09:05
View Session

At this event

Prev

Next

Dr. Stefan Warmuth, PhD

SVP, Head Technology and CMC

Numab Therapeutics AG